ABSTRACT
@#In recent years, more and more attention has been paid to the correlation between periodontitis and prostatic diseases. Aging, obesity, smoking and psychological factors are common risk factors of these two diseases, but the key correlation mechanism is not clear. This article reviews the research on and possible biological mechanism of chronic periodontitis and prostatic diseases, in order to provide basis for disease management and clinical research in the future.
ABSTRACT
Objective@#To detect the expression of matrix metalloproteinase-3 (MMP-3) in serum and gingival crevicular fluid in patients with rheumatoid arthritis (RA) and its correlation with chronic periodontitis (CP).@*Methods@#From March 2017 to July 2018, 26 patients with RA and CP [CP+RA group, (54.9±6.5) years old, 4 males and 22 females], 22 patients with RA only [RA group, (49.6±11.7) years old,5 males and 17 females] in the Department of Rheumatology and Immunology, Shengjing Hospital Affiliated to China Medical University, 22 patients with simple CP in the Department of Stomatology, Shengjing Hospital Affiliated to China Medical University [CP group, (51.4±12.5) years old, 8 males and 14 females] and 18 generally healthy controls in Physical Examination Center of Shengjing Hospital Affiliated to China Medical University [group H, (49.4±9.1) years old, 8 males and 10 females] were recruited. There were no significant differences in age and sex ratio amongst 4 groups. Patient′s general status, probing depth (PD) , clinical attachment loss (CAL), sulcus bleeding index (SBI), simplified calculus index (CI-S) and simplified debris index (DI-S) were recorded in 4 groups. Samples of serum and gingival crevicular fluid were collected from patients of each group, and the expression levels of MMP-3 in serum and gingival crevicular fluid samples were detected by using enzyme-linked immunosorbent assay. Erythrocyte sedimentation rate, rheumatoid factor, anti-cyclic citrulline peptide antibody and C-reactive protein were detected in the serum of subjects in RA group and CP+RA group. Correlation analysis was conducted between MMP-3 expression level and periodontal indices amongst 4 groups. The results were statistically analyzed using the SPSS 20.0 software package.@*Results@#The indices of CAL [(4.12±1.13) mm], SBI (2.58±0.64) and DI-S (2.65±0.69) in CP+RA group were significantly higher than indices of CAL [(3.00±0.00) mm], SBI (2.59±1.05) and DI-S, (2.36±0.49) in CP group (P<0.05); The expression levels of MMP-3 in serum samples of CP+RA group [(1 1645.6±6 903.4) μg/L] and CP group [(9 337.0±6 719.0) μg/L] were significantly higher than that of RA group [(2 389.9±1 320.3) μg/L] and H group [(1 493.5±292.1) μg/L] (P<0.05). The expression level of MMP-3 in gingival crevicular fluid samples of CP+RA group [(164.4±45.3) μg/L] was significantly higher than that of CP group [(84.6±92.5) μg/L], RA group [(49.0±18.1) μg/L] and H group [(20.4±6.3) μg/L] (P<0.05), respectively. The erythrocyte sedimentation rate, rheumatoid factor and anti-cyclic cirullinated peptide antibodies levels in the CP+RA group were significantly higher than those in the RA group (P<0.05). The expression level of MMP-3 in serum is positively correlated with PD (r=0.45, P=0.04) and the expression level of MMP-3 in gingival crevicular fluid is positively correlated with CAL (r=0.58, P<0.01).@*Conclusions@#The levels of MMP-3 in serum and gingival crevicular fluid of patients with RA and CP were significantly increased. MMP-3 may be associated with the development of CP and RA.
ABSTRACT
Objective To explorethe efficacy of anticoagulation therapy with peripherally inserted central venous catheter (PICC) for prevention of venous thrombosis in patients with lung cancer with hypercoagulability. Methods During the period from August 2015 to December 2016,30 patients in our hospital were enrolled as the observation group, and 30 patients from May 2014 to July 2015, with lung cancer treated with PICC catheter in our hospital were selected as the control group.In the control group, PICC during intubation by conventional methods to prevent the occurrence of venous thrombosis;while in the observation group with the additional treatment before and after anticoagulant therapy catheter based on routine prevention. Venous thrombosis incidence and the indwelling time of PICC were compared between two groups. Results The incidence of thrombosis in observation and control groups was 0 and 20% respectively,with significant difference between the two groups(P=0.024).The PICC retention time in observation group and control group was 95.5 (21.00, 117.25) days and 108 (97.00,130.25) days, the difference between the two groups was statistically significant (Z =-2.249, P = 0.025). Conclusions Anticoagulation treatment with PICC catheter before and after in hypercoagulability lung cancer patients can significantly improve the hypercoagulable state of patients,effectively prevent venous thrombosis,and prolong the PICC retention time.
ABSTRACT
Objective To investigate the expression levels of adiponectin and visfatin in the gingival crevicular fluid (GCF) and serum of patients with obesity and chronic periodontitis.Methods The study included 80 patients.Among them,20 were healthy controls (H group),20 had periodontitis (CP group),20 had obesity (OB group),and 20 had both obesity and periodontitis (OB+CP group).The patients' baseline information and clinical parameters were recorded,and the GCF and serum were collected.The concentration of adiponectin and visfatin in the GCF and serum were then assayed using ELISA.Use the SPSS 17.0 software package for statistical analysis.Results The concentration of adiponectin in the serum of the CP group,the OB group,and the OB+CP group were significantly lower than that of the H group (P ＜ 0.05).The concentration of adiponectin in the serum of the OB+CP group was lower than that of both the CP and OB groups (P ＜ 0.05).The concentration of adiponectin in the GCF of the CP group,the OB group,and the H group were higher than that of the OB+CP group (P ＜ 0.05).The concentration of adiponectin in the GCF of the CP group,the OB group,and the H group were lower than that of the OB+CP group (P ＜ 0.05).Conclusion Obesity may aggravate the destruction of periodontal tissue by inhibiting the expression of adiponectin and promoting the expression of visfatin.
ABSTRACT
Objective To evaluate the value of 18 F-FDG PET/CT imaging in predicting the progno-sis of newly diagnosed SCLC with normal serum LDH ( SCLC-nsLDH) . Methods A total of 68 SCLC pa-tients (59 males, 9 females, median age:58.5 years) proved by pathology between June 2005 and Decem-ber 2016 were retrospectively analyzed. All patients underwent 18 F-FDG PET/CT. The general information of patients, including LDH, NSE, OS, PFS and SUVmax , were recorded. SUVmax differences were analyzed with Mann-Whitney u test. Life-table method and Kaplan-Meier analysis were used to estimate the survival rate and median survival time. The survival function curve was drawn. Log-rank test was used to analyze whether there existed statistical differences in survival period among different groups. Cox regression analysis was used for screening the influencing factors of prognosis. Results ( 1) In 68 SCLC patients, there were 38 cases with limited disease ( LD) and 30 cases with extensive disease ( ED) . There were 3 cases in stageⅠ, 7 cases in stage Ⅱ, 29 cases in stage Ⅲ, 29 cases in stage Ⅳ. The median SUVmax of the primary tumor was 11.35 (9.90, 13.90). There was no significant difference between the median SUVmax of LD group and that of ED group:11.05(9.72, 13.60) vs 12.25(10. 05, 14.12)months;z=-0.797, P=0.426. The median serum LDH was 195.15(171.00, 220.80) U/L. (2) The median follow-up time was 18(range:2-101) months. The disease developed in 46 patients and 35 patients died. The median OS was 23 (95%CI:13.3-32.7) months and median PFS was 17 (95% CI: 11.4-22.6) months. (3) ROC curve showed the optimal SUVmax cutoff value was 10.85. The OS of patients with SUVmax≤10.85 ( n=25) and with SUVmax>10.85 (n=43) were 40.0(95% CI:2.5-77.5) months and 18.0(95% CI:13.3-22.7) months(χ2=8.956, P=0.003), respectively. (4)Weight loss, VALG stage and primary tumor SUVmax were independent prog-nostic factors for OS (all P<0.05). Only VALG stage was an independent prognostic factor for PFS (P<0. 001) . Conclusion 18 F-FDG PET/CT can help to differentiate the different prognosis of SCLC-nsLDH patients, and provide more evidence for the choice of individual treatment strategy.
ABSTRACT
Objective To evaluate the value of 18 F-FDG PET/CT imaging in predicting the progno-sis of newly diagnosed SCLC with normal serum LDH ( SCLC-nsLDH) . Methods A total of 68 SCLC pa-tients (59 males, 9 females, median age:58.5 years) proved by pathology between June 2005 and Decem-ber 2016 were retrospectively analyzed. All patients underwent 18 F-FDG PET/CT. The general information of patients, including LDH, NSE, OS, PFS and SUVmax , were recorded. SUVmax differences were analyzed with Mann-Whitney u test. Life-table method and Kaplan-Meier analysis were used to estimate the survival rate and median survival time. The survival function curve was drawn. Log-rank test was used to analyze whether there existed statistical differences in survival period among different groups. Cox regression analysis was used for screening the influencing factors of prognosis. Results ( 1) In 68 SCLC patients, there were 38 cases with limited disease ( LD) and 30 cases with extensive disease ( ED) . There were 3 cases in stageⅠ, 7 cases in stage Ⅱ, 29 cases in stage Ⅲ, 29 cases in stage Ⅳ. The median SUVmax of the primary tumor was 11.35 (9.90, 13.90). There was no significant difference between the median SUVmax of LD group and that of ED group:11.05(9.72, 13.60) vs 12.25(10. 05, 14.12)months;z=-0.797, P=0.426. The median serum LDH was 195.15(171.00, 220.80) U/L. (2) The median follow-up time was 18(range:2-101) months. The disease developed in 46 patients and 35 patients died. The median OS was 23 (95%CI:13.3-32.7) months and median PFS was 17 (95% CI: 11.4-22.6) months. (3) ROC curve showed the optimal SUVmax cutoff value was 10.85. The OS of patients with SUVmax≤10.85 ( n=25) and with SUVmax>10.85 (n=43) were 40.0(95% CI:2.5-77.5) months and 18.0(95% CI:13.3-22.7) months(χ2=8.956, P=0.003), respectively. (4)Weight loss, VALG stage and primary tumor SUVmax were independent prog-nostic factors for OS (all P<0.05). Only VALG stage was an independent prognostic factor for PFS (P<0. 001) . Conclusion 18 F-FDG PET/CT can help to differentiate the different prognosis of SCLC-nsLDH patients, and provide more evidence for the choice of individual treatment strategy.
ABSTRACT
[Objective]To investigate the prognostic value of 18F-FDG PET/CT with different metabolic parameters in newly diagnosed limited-disease(LD)small cell lung cancer(SCLC).[Methods]Retrospective analysis was carried out in the patients between June 2005 to December 2016 in our hospital confirmed of LD SCLC by pathology or cytology and comprehensive imaging. Fifty-four patients were recruited. Record the general characteristics of patients,pre-treatment KPS score,smoking status,weight loss,serum LDH,NSE,OS,PFS. All lesions(primary lesions + metastases)were sketched out within one VOI,and the SUVmax, SUVmean and SUVpeak in the VOI were automatically measured and recorded. The automatic measurement was performed by the fixed threshold method. The thresholds of tumor of MTV and TLG were 40% and 50% of SUVmax. The TLG and MTV were identified as TLG40%,TLG50%,MTV40% and MTV50% respectively. Kaplan-Meier method was used for survival analysis. All the prognostic factors were analyzed by Cox model.[Result]The median SUVmax was 13.92(2.61~43.28),the median of SUVmean was 8.31(1.71~26.85) and the median of SUVpeak was 10.51(1.49 ~ 27.48). The median of TLG40% was 340.22(16.58 ~ 2827.26),the median of TLG50%was 215.645(1.70 ~ 2270.36),the median of MTV40% was 36.71(1.15 ~ 259.47 cm3),the median of MTV50% was 19.65(0.93 ~1900.00)cm3. Univariate and multivariate analysis of metabolic index and prognosis showed that TLG50% was the prognostic factor of OS(P = 0.013),but not of PFS(P > 0.05). The SUVmax,SUVmean and SUVpeak were not the prognostic factors of OS and PFS(P >0.05).[Conclusion]The volume metabolic parameters TLG50%was the independent prognostic factor of the overall survival time of the LD SCLC. The volume metabolic parameters (TLG and MTV) of 18F-FDG PET/CT were related to the prognosis of SCLC ,which could provide the basis for individual chemotherapy.
ABSTRACT
Objectives: This study aimed to investigate the hypoxic status of nasopharyngeal carcinoma [NPC] before and after three-dimensional conformal radiotherapy [3-D CRT] and the correlation between hypoxic changes and radiotherapy curative effects
Design: Retrospective study
Setting: Department of Nuclear Medicine, Sun Yat-sen University Cancer Center; Guangzhou, China
Subjects: Routine techneyium-99m 4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime [99mTc-HL91] single photon emission tomography [SPECT] of the nasopharynx and neck was performed before and after 3-D CRT in 38 patients with NPC
Interventions: An analysis of the target/non-target [T/N] value of the focus was performed
Main outcome measure: T/N value of the nasopharyngeal focus and neck
Results: The focus hypoxic examination of 32 of 38 patients was positive [84%]. T/N values for hypoxic status in the 32 patients with a positive nasopharyngeal focus and normal tissue were 1.89 +/- 0.95 and 1.18 +/- 0.36, respectively. The mean T/N values for NPC hypoxic focus before and after radiotherapy were significantly different among the 32 patients. The hypoxic status of the nasopharyngeal focus positively correlated with its response to radiotherapy. The correlation coefficient was 0.641
Conclusions: 99mTc-HL91 hypoxic imaging can reveal the hypoxic status of the NPC focus. The hypoxic status of NPC was closely correlated with the curative effect of 3-D CRT
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the effect of Am80 on innate immune response of Porphyromonas gingivalis (Pg) W83-induced periodontitis in mice.</p><p><b>METHODS</b>Twenty-five mice were randomly divided into five groups, control group, PgW83-induced periodontitis group (periodontitis), Am80 (10 µg/d) treatment group (low-dose group), Am80 (50 µg/d) treatment group (middle-dose group), Am80 (100 µg/d) treatment group (high-dose group). The distance of alveolar bone resorption in each mouse was observed and measured by a dissecting microscope. Enzyme-linked immunosorbent assay (ELISA) was used to detect the level of serum anti-Pg specific IgG. The mRNA expression of interferon-γ (IFN-γ) and interleuking-12 (IL-12) in gingival tissues, draining lymph node and spleen were detected by real-time reverse transcriptase polymerase chain reaction (RT-PCR). The measurement data were statistically analyzed.</p><p><b>RESULTS</b>The resorption rate in Am80 group [(121 ± 10)%] and high-dose of Am80 group [(108 ± 8)%] was significantly different with that in periodontitis mice [(133 ± 10)% ] (P < 0.05). The serum levels of anti-Pg specific IgG of the Am80 groups of different doses (0.437 ± 0.083, 0.566 ± 0.012, and 0.386 ± 0.078) were significantly lower than that of the periodontitis group (1.151 ± 0.433) (P < 0.001). Real-time quantitative PCR assay showed that after Am80 treatment, the IL-12 mRNA levels in the gingival tissues, lymph nodes and spleen of mice were reduced to 1.107 ± 0.088, 0.806 ± 0.220, and 0.668 ± 0.756, which were all significantly different with those in periodontitis (P < 0.01). Similarly, the relative expression of IFN-γ mRNA levels in gingival tissue, lymph nodes and spleen of mice were reduced to 8.898 ± 0.427, 16.654 ± 5.995, and 1.482 ± 0.033, which were significantly different with periodontitis (P < 0.001).</p><p><b>CONCLUSIONS</b>Am80 can reduce the extent of inflammation and alleviate alveolar bone resorption by modulating innate immune response.</p>
Subject(s)
Animals , Mice , Alveolar Bone Loss , Pathology , Benzoates , Pharmacology , Gingiva , Allergy and Immunology , Immunity, Innate , Immunoglobulin G , Blood , Interferon-gamma , Genetics , Metabolism , Interleukin-12 , Blood , Periodontitis , Blood , Allergy and Immunology , Microbiology , Porphyromonas gingivalis , Allergy and Immunology , RNA, Messenger , Random Allocation , Spleen , Allergy and Immunology , Tetrahydronaphthalenes , PharmacologyABSTRACT
OBJECTIVE@#To evaluate the effect of allergen specific immunotherapy (SIT) in patients with allergic rhinitis and asthma. METHOD A total of 68 patients with allergic rhinitis and asthma sensitized to dust mite were recruited into the study. They were randomly divided into two groups: SIT group n = 34 and symptomatic therapy (ST) group: n = 34. Patients in ST group received medication to treat, the symptoms, patients in SIT group received medication and 3 years of standardized allergen vaccine therapy. Evaluation index of therapy includes: rhinitis symptoms score, asthma symptoms score, drug score, skin prick test, serum specificity IgE (sIgE) , peripheral eosinophil (Eos) counting, lung function. The new sensitinogen rate was also assessed.@*RESULT@#Clinical symptom scores, drug scores, lung function, blood eosinophil numbers and skin test result were all improved significantly after 3-year treatment in SIT group compared to those in ST group (P < 0.01). Although the level of serum slgE was decreased,there exited no statistic diferences between two groups. Only 8.8% patients have the new sensitization in SIT group, and 52.9% in ST group. There were no serious adverse reactions in treatment process.@*CONCLUSION@#SIT for patients with AR and asthma can obtain excellent clinical efficacy.